KEYNOTE-564: Phase 3 trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma (RCC)

Choueiri, TK; Powles, T; Zhang, T; Quinn, DI; Gschwend, JE; Wan, SS; Poehlein, C

ANNALS OF ONCOLOGY, 2017; 28 ( ):